The MHT CET 2025 syllabus follows the Maharashtra SCERT curriculum, with 20 per cent weightage from Class 11 and 80 per cent ...
The detailed RBI Grade B Phase II exam pattern can be found in the table below for reference. RBI Grade B Syllabus for General Posts Phase-I includes topics from General Awareness, English Language, ...
Jagran Josh provides here the mock tests and video courses prepared by subject matter experts, exclusively for ICSE Class 10. Students must utilise this lucrative study material to clear concepts ...
Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...
Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for ... FDA-approved hemophilia B gene therapy Beqvez off ...
Healthcare firm Alliance Pharma has backed a sweetened £362 million takeover offer by its largest shareholder and activist investor DBay Advisors. The deal – the sixth by DBay – will see ...
Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...
MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...
March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...
Healthcare firm Alliance Pharma has backed a sweetened £362 million takeover offer by its largest shareholder and activist investor DBay Advisors (Kirsty O’Connor/PA) Healthcare firm Alliance ...
Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.
J. B. Chemicals & Pharmaceuticals Limited’s DJSI score is 77, which will rank presently among the leading pharmaceutical companies in India and also rank among the leaders in Pharma Globally (Sector: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果